id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_1000
split_0_train_1000
[ { "id": "split_0_train_1000_passage", "type": "progene_text", "text": [ "None of the anti - beta subunit antibodies reacted with protein extracts of E. coli host cells , suggesting that these bacteria have no beta subunit protein ." ], "offsets": [ [ 0, 158 ] ] } ]
[]
[]
[]
[]
split_0_train_1001
split_0_train_1001
[ { "id": "split_0_train_1001_passage", "type": "progene_text", "text": [ "Interestingly , the rbeta subunit associated with E. coli as well as human MAT alpha subunits ." ], "offsets": [ [ 0, 95 ] ] } ]
[ { "id": "split_0_train_1374_entity", "type": "progene_text", "text": [ "MAT alpha" ], "offsets": [ [ 75, 84 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1002
split_0_train_1002
[ { "id": "split_0_train_1002_passage", "type": "progene_text", "text": [ "This association changed the kinetic properties of both enzymes and lowered the K(m) of MAT for L-methionine ." ], "offsets": [ [ 0, 110 ] ] } ]
[ { "id": "split_0_train_1375_entity", "type": "progene_text", "text": [ "MAT" ], "offsets": [ [ 88, 91 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1003
split_0_train_1003
[ { "id": "split_0_train_1003_passage", "type": "progene_text", "text": [ "Together , the data show that we have cloned and expressed the human MAT II beta subunit and confirmed its long suspected regulatory function ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_1376_entity", "type": "progene_text", "text": [ "MAT II beta" ], "offsets": [ [ 69, 80 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1004
split_0_train_1004
[ { "id": "split_0_train_1004_passage", "type": "progene_text", "text": [ "This knowledge affords a molecular means by which MAT activity and consequently the levels of AdoMet may be modulated in mammalian cells ." ], "offsets": [ [ 0, 138 ] ] } ]
[ { "id": "split_0_train_1377_entity", "type": "progene_text", "text": [ "MAT" ], "offsets": [ [ 50, 53 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1005
split_0_train_1005
[ { "id": "split_0_train_1005_passage", "type": "progene_text", "text": [ "Palindromes as substrates for multiple pathways of recombination in Escherichia coli ." ], "offsets": [ [ 0, 86 ] ] } ]
[]
[]
[]
[]
split_0_train_1006
split_0_train_1006
[ { "id": "split_0_train_1006_passage", "type": "progene_text", "text": [ "A 246 - bp imperfect palindrome has the potential to form hairpin structures in single - stranded DNA during replication ." ], "offsets": [ [ 0, 122 ] ] } ]
[]
[]
[]
[]
split_0_train_1007
split_0_train_1007
[ { "id": "split_0_train_1007_passage", "type": "progene_text", "text": [ "Genetic evidence suggests that these structures are converted to double - strand breaks by the SbcCD nuclease and that the double - strand breaks are repaired by recombination ." ], "offsets": [ [ 0, 177 ] ] } ]
[ { "id": "split_0_train_1378_entity", "type": "progene_text", "text": [ "SbcCD nuclease" ], "offsets": [ [ 95, 109 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1008
split_0_train_1008
[ { "id": "split_0_train_1008_passage", "type": "progene_text", "text": [ "We investigated the role of a range of recombination mutations on the viability of cells containing this palindrome ." ], "offsets": [ [ 0, 117 ] ] } ]
[]
[]
[]
[]
split_0_train_1009
split_0_train_1009
[ { "id": "split_0_train_1009_passage", "type": "progene_text", "text": [ "The palindrome was introduced into the Escherichia coli chromosome by phage lambda lysogenization ." ], "offsets": [ [ 0, 99 ] ] } ]
[]
[]
[]
[]
split_0_train_1010
split_0_train_1010
[ { "id": "split_0_train_1010_passage", "type": "progene_text", "text": [ "This was done in both wt and sbcC backgrounds ." ], "offsets": [ [ 0, 47 ] ] } ]
[ { "id": "split_0_train_1379_entity", "type": "progene_text", "text": [ "sbcC" ], "offsets": [ [ 29, 33 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1011
split_0_train_1011
[ { "id": "split_0_train_1011_passage", "type": "progene_text", "text": [ "Repair of the SbcCD - induced double - strand breaks requires a large number of proteins , including the components of both the RecB and RecF pathways ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_1380_entity", "type": "progene_text", "text": [ "SbcCD" ], "offsets": [ [ 14, 19 ] ], "normalized": [] }, { "id": "split_0_train_1381_entity", "type": "progene_text", "text": [ "RecB" ], "offsets": [ [ 128, 132 ] ], "normalized": [] }, { "id": "split_0_train_1382_entity", "type": "progene_text", "text": [ "RecF" ], "offsets": [ [ 137, 141 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1012
split_0_train_1012
[ { "id": "split_0_train_1012_passage", "type": "progene_text", "text": [ "Repair does not involve PriA - dependent replication fork restart , which suggests that the double - strand break occurs after the replication fork has passed the palindrome ." ], "offsets": [ [ 0, 175 ] ] } ]
[ { "id": "split_0_train_1383_entity", "type": "progene_text", "text": [ "PriA" ], "offsets": [ [ 24, 28 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1013
split_0_train_1013
[ { "id": "split_0_train_1013_passage", "type": "progene_text", "text": [ "In the absence of SbcCD , recombination still occurs , probably using a gap substrate ." ], "offsets": [ [ 0, 87 ] ] } ]
[ { "id": "split_0_train_1384_entity", "type": "progene_text", "text": [ "SbcCD" ], "offsets": [ [ 18, 23 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1014
split_0_train_1014
[ { "id": "split_0_train_1014_passage", "type": "progene_text", "text": [ "This process is also PriA independent , suggesting that there is no collapse of the replication fork ." ], "offsets": [ [ 0, 102 ] ] } ]
[ { "id": "split_0_train_1385_entity", "type": "progene_text", "text": [ "PriA" ], "offsets": [ [ 21, 25 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1015
split_0_train_1015
[ { "id": "split_0_train_1015_passage", "type": "progene_text", "text": [ "In the absence of RecA , the RecQ helicase is required for palindrome viability in a sbcC mutant , suggesting that a helicase - dependent pathway exists to allow replicative bypass of secondary structures ." ], "offsets": [ [ 0, 206 ] ] } ]
[ { "id": "split_0_train_1386_entity", "type": "progene_text", "text": [ "RecA" ], "offsets": [ [ 18, 22 ] ], "normalized": [] }, { "id": "split_0_train_1387_entity", "type": "progene_text", "text": [ "RecQ" ], "offsets": [ [ 29, 33 ] ], "normalized": [] }, { "id": "split_0_train_1388_entity", "type": "progene_text", "text": [ "helicase" ], "offsets": [ [ 34, 42 ] ], "normalized": [] }, { "id": "split_0_train_1389_entity", "type": "progene_text", "text": [ "sbcC" ], "offsets": [ [ 85, 89 ] ], "normalized": [] }, { "id": "split_0_train_1390_entity", "type": "progene_text", "text": [ "helicase" ], "offsets": [ [ 117, 125 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1016
split_0_train_1016
[ { "id": "split_0_train_1016_passage", "type": "progene_text", "text": [ "Flt3 ligand ( FL ) and its influence on immune reactivity ." ], "offsets": [ [ 0, 59 ] ] } ]
[ { "id": "split_0_train_1391_entity", "type": "progene_text", "text": [ "Flt3 ligand" ], "offsets": [ [ 0, 11 ] ], "normalized": [] }, { "id": "split_0_train_1392_entity", "type": "progene_text", "text": [ "FL" ], "offsets": [ [ 14, 16 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1017
split_0_train_1017
[ { "id": "split_0_train_1017_passage", "type": "progene_text", "text": [ "Flt3 ( fms - like tyrosine kinase 3 ) ligand ( FL ) is a potent hematopoietic cytokine that affects the growth and differentiation of progenitor and stem cells both in vivo and in vitro ." ], "offsets": [ [ 0, 187 ] ] } ]
[ { "id": "split_0_train_1393_entity", "type": "progene_text", "text": [ "Flt3 ( fms - like tyrosine kinase 3 ) ligand" ], "offsets": [ [ 0, 44 ] ], "normalized": [] }, { "id": "split_0_train_1394_entity", "type": "progene_text", "text": [ "FL" ], "offsets": [ [ 47, 49 ] ], "normalized": [] }, { "id": "split_0_train_1395_entity", "type": "progene_text", "text": [ "cytokine" ], "offsets": [ [ 78, 86 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1018
split_0_train_1018
[ { "id": "split_0_train_1018_passage", "type": "progene_text", "text": [ "Its capacity to augment strikingly the numbers of dendritic cells ( rare antigen - presenting cells that induce and regulate immune responses ) in mice and humans has stimulated considerable interest in its value as an investigational tool and therapeutic agent ." ], "offsets": [ [ 0, 263 ] ] } ]
[]
[]
[]
[]
split_0_train_1019
split_0_train_1019
[ { "id": "split_0_train_1019_passage", "type": "progene_text", "text": [ "In this review , we survey the hematopoietic properties and immunobiology of FL , and examine its therapeutic potential ." ], "offsets": [ [ 0, 121 ] ] } ]
[ { "id": "split_0_train_1396_entity", "type": "progene_text", "text": [ "FL" ], "offsets": [ [ 77, 79 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1020
split_0_train_1020
[ { "id": "split_0_train_1020_passage", "type": "progene_text", "text": [ "Distribution of PDE4A and G(o) alpha immunoreactivity in the accessory olfactory system of the mouse ." ], "offsets": [ [ 0, 102 ] ] } ]
[ { "id": "split_0_train_1397_entity", "type": "progene_text", "text": [ "PDE4A" ], "offsets": [ [ 16, 21 ] ], "normalized": [] }, { "id": "split_0_train_1398_entity", "type": "progene_text", "text": [ "G(o) alpha" ], "offsets": [ [ 26, 36 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1021
split_0_train_1021
[ { "id": "split_0_train_1021_passage", "type": "progene_text", "text": [ "Distribution of the cAMP - specific phosphodiesterase PDE4A was examined in the accessory olfactory system by immunohistochemistry ." ], "offsets": [ [ 0, 132 ] ] } ]
[ { "id": "split_0_train_1399_entity", "type": "progene_text", "text": [ "phosphodiesterase" ], "offsets": [ [ 36, 53 ] ], "normalized": [] }, { "id": "split_0_train_1400_entity", "type": "progene_text", "text": [ "PDE4A" ], "offsets": [ [ 54, 59 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1022
split_0_train_1022
[ { "id": "split_0_train_1022_passage", "type": "progene_text", "text": [ "Adjacent sections through the vomeronasal organ ( VNO ) and accessory olfactory bulb ( AOB ) were alternately immunostained with antibodies against PDE4A or the G - protein alpha subunit G ( o ) alpha , which labels basal VNO neurons , in order to determine whether PDE4A occurs preferentially in one of two segregated VNO pathways ." ], "offsets": [ [ 0, 333 ] ] } ]
[ { "id": "split_0_train_1401_entity", "type": "progene_text", "text": [ "PDE4A" ], "offsets": [ [ 148, 153 ] ], "normalized": [] }, { "id": "split_0_train_1402_entity", "type": "progene_text", "text": [ "G - protein alpha" ], "offsets": [ [ 161, 178 ] ], "normalized": [] }, { "id": "split_0_train_1403_entity", "type": "progene_text", "text": [ "G ( o ) alpha" ], "offsets": [ [ 187, 200 ] ], "normalized": [] }, { "id": "split_0_train_1404_entity", "type": "progene_text", "text": [ "PDE4A" ], "offsets": [ [ 266, 271 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1023
split_0_train_1023
[ { "id": "split_0_train_1023_passage", "type": "progene_text", "text": [ "We found that PDE4A strongly labeled apical VNO neurons and rostral AOB glomeruli ." ], "offsets": [ [ 0, 83 ] ] } ]
[ { "id": "split_0_train_1405_entity", "type": "progene_text", "text": [ "PDE4A" ], "offsets": [ [ 14, 19 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1024
split_0_train_1024
[ { "id": "split_0_train_1024_passage", "type": "progene_text", "text": [ "There was virtually no overlap in G(o) alpha and PDE4A staining , and there were no regions of the VNO neuroepithelium or AOB glomeruli not labeled by either antibody ." ], "offsets": [ [ 0, 168 ] ] } ]
[ { "id": "split_0_train_1406_entity", "type": "progene_text", "text": [ "G(o) alpha" ], "offsets": [ [ 34, 44 ] ], "normalized": [] }, { "id": "split_0_train_1407_entity", "type": "progene_text", "text": [ "PDE4A" ], "offsets": [ [ 49, 54 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1025
split_0_train_1025
[ { "id": "split_0_train_1025_passage", "type": "progene_text", "text": [ "These results identify a potential member of the pheromone transduction cascade in apical neurons , and provide further evidence that the VNO consists of functionally distinct pathways ." ], "offsets": [ [ 0, 186 ] ] } ]
[]
[]
[]
[]
split_0_train_1026
split_0_train_1026
[ { "id": "split_0_train_1026_passage", "type": "progene_text", "text": [ "Interactions among components of the Salmonella flagellar export apparatus and its substrates ." ], "offsets": [ [ 0, 95 ] ] } ]
[]
[]
[]
[]
split_0_train_1027
split_0_train_1027
[ { "id": "split_0_train_1027_passage", "type": "progene_text", "text": [ "We have examined the cytoplasmic components ( FliH , FliI and FliJ ) of the type III flagellar protein export apparatus , plus the cytoplasmic domains ( FlhAC and FlhBC ) of two of its six membrane components ." ], "offsets": [ [ 0, 210 ] ] } ]
[ { "id": "split_0_train_1408_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 46, 50 ] ], "normalized": [] }, { "id": "split_0_train_1409_entity", "type": "progene_text", "text": [ "FliI" ], "offsets": [ [ 53, 57 ] ], "normalized": [] }, { "id": "split_0_train_1410_entity", "type": "progene_text", "text": [ "FliJ" ], "offsets": [ [ 62, 66 ] ], "normalized": [] }, { "id": "split_0_train_1411_entity", "type": "progene_text", "text": [ "FlhAC" ], "offsets": [ [ 153, 158 ] ], "normalized": [] }, { "id": "split_0_train_1412_entity", "type": "progene_text", "text": [ "FlhBC" ], "offsets": [ [ 163, 168 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1028
split_0_train_1028
[ { "id": "split_0_train_1028_passage", "type": "progene_text", "text": [ "FliH , FlhAC and FliJ , when overproduced , caused inhibition of motility of wild - type cells and inhibition of the export of substrates such as the hook protein FlgE ." ], "offsets": [ [ 0, 169 ] ] } ]
[ { "id": "split_0_train_1413_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_1414_entity", "type": "progene_text", "text": [ "FlhAC" ], "offsets": [ [ 7, 12 ] ], "normalized": [] }, { "id": "split_0_train_1415_entity", "type": "progene_text", "text": [ "FliJ" ], "offsets": [ [ 17, 21 ] ], "normalized": [] }, { "id": "split_0_train_1416_entity", "type": "progene_text", "text": [ "hook protein" ], "offsets": [ [ 150, 162 ] ], "normalized": [] }, { "id": "split_0_train_1417_entity", "type": "progene_text", "text": [ "FlgE" ], "offsets": [ [ 163, 167 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1029
split_0_train_1029
[ { "id": "split_0_train_1029_passage", "type": "progene_text", "text": [ "Co - overproduction of FliH and FliI substantially relieved the inhibition caused by FliH , suggesting that it is excess free FliH that is inhibitory and that FliH and FliI form a complex ." ], "offsets": [ [ 0, 189 ] ] } ]
[ { "id": "split_0_train_1418_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 23, 27 ] ], "normalized": [] }, { "id": "split_0_train_1419_entity", "type": "progene_text", "text": [ "FliI" ], "offsets": [ [ 32, 36 ] ], "normalized": [] }, { "id": "split_0_train_1420_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 85, 89 ] ], "normalized": [] }, { "id": "split_0_train_1421_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 126, 130 ] ], "normalized": [] }, { "id": "split_0_train_1422_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 159, 163 ] ], "normalized": [] }, { "id": "split_0_train_1423_entity", "type": "progene_text", "text": [ "FliI" ], "offsets": [ [ 168, 172 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1030
split_0_train_1030
[ { "id": "split_0_train_1030_passage", "type": "progene_text", "text": [ "We purified His-FLAG - tagged versions of : ( i ) export components FliH , FliI , FliJ , FlhAC and FlhBC ; ( ii ) rod / hook - type export substrates FlgB ( rod protein ) , FlgE ( hook protein ) , FlgD ( hook capping protein ) and FliE ( basal body protein ) ; and ( iii ) filament - type export substrates FlgK and FlgL ( hook - filament junction proteins ) and FliC ( flagellin ) ." ], "offsets": [ [ 0, 383 ] ] } ]
[ { "id": "split_0_train_1424_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 68, 72 ] ], "normalized": [] }, { "id": "split_0_train_1425_entity", "type": "progene_text", "text": [ "FliI" ], "offsets": [ [ 75, 79 ] ], "normalized": [] }, { "id": "split_0_train_1426_entity", "type": "progene_text", "text": [ "FliJ" ], "offsets": [ [ 82, 86 ] ], "normalized": [] }, { "id": "split_0_train_1427_entity", "type": "progene_text", "text": [ "FlhAC" ], "offsets": [ [ 89, 94 ] ], "normalized": [] }, { "id": "split_0_train_1428_entity", "type": "progene_text", "text": [ "FlhBC" ], "offsets": [ [ 99, 104 ] ], "normalized": [] }, { "id": "split_0_train_1429_entity", "type": "progene_text", "text": [ "FlgB" ], "offsets": [ [ 150, 154 ] ], "normalized": [] }, { "id": "split_0_train_1430_entity", "type": "progene_text", "text": [ "rod protein" ], "offsets": [ [ 157, 168 ] ], "normalized": [] }, { "id": "split_0_train_1431_entity", "type": "progene_text", "text": [ "FlgE" ], "offsets": [ [ 173, 177 ] ], "normalized": [] }, { "id": "split_0_train_1432_entity", "type": "progene_text", "text": [ "hook protein" ], "offsets": [ [ 180, 192 ] ], "normalized": [] }, { "id": "split_0_train_1433_entity", "type": "progene_text", "text": [ "FlgD" ], "offsets": [ [ 197, 201 ] ], "normalized": [] }, { "id": "split_0_train_1434_entity", "type": "progene_text", "text": [ "hook capping protein" ], "offsets": [ [ 204, 224 ] ], "normalized": [] }, { "id": "split_0_train_1435_entity", "type": "progene_text", "text": [ "FliE" ], "offsets": [ [ 231, 235 ] ], "normalized": [] }, { "id": "split_0_train_1436_entity", "type": "progene_text", "text": [ "basal body protein" ], "offsets": [ [ 238, 256 ] ], "normalized": [] }, { "id": "split_0_train_1437_entity", "type": "progene_text", "text": [ "FlgK" ], "offsets": [ [ 307, 311 ] ], "normalized": [] }, { "id": "split_0_train_1438_entity", "type": "progene_text", "text": [ "FlgL" ], "offsets": [ [ 316, 320 ] ], "normalized": [] }, { "id": "split_0_train_1439_entity", "type": "progene_text", "text": [ "hook - filament junction proteins" ], "offsets": [ [ 323, 356 ] ], "normalized": [] }, { "id": "split_0_train_1440_entity", "type": "progene_text", "text": [ "FliC" ], "offsets": [ [ 363, 367 ] ], "normalized": [] }, { "id": "split_0_train_1441_entity", "type": "progene_text", "text": [ "flagellin" ], "offsets": [ [ 370, 379 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1031
split_0_train_1031
[ { "id": "split_0_train_1031_passage", "type": "progene_text", "text": [ "We tested for protein - protein interactions by affinity blotting ." ], "offsets": [ [ 0, 67 ] ] } ]
[]
[]
[]
[]
split_0_train_1032
split_0_train_1032
[ { "id": "split_0_train_1032_passage", "type": "progene_text", "text": [ "In many cases , a given protein interacted with more than one other component , indicating that there are likely to be multiple dynamic interactions or interactions that involve more than two components ." ], "offsets": [ [ 0, 204 ] ] } ]
[]
[]
[]
[]
split_0_train_1033
split_0_train_1033
[ { "id": "split_0_train_1033_passage", "type": "progene_text", "text": [ "Interactions of FlhBC with rod / hook - type substrates were strong , whereas those with filament - type substrates were very weak ; this may reflect the role of FlhB in substrate specificity switching ." ], "offsets": [ [ 0, 203 ] ] } ]
[ { "id": "split_0_train_1442_entity", "type": "progene_text", "text": [ "FlhBC" ], "offsets": [ [ 16, 21 ] ], "normalized": [] }, { "id": "split_0_train_1443_entity", "type": "progene_text", "text": [ "FlhB" ], "offsets": [ [ 162, 166 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1034
split_0_train_1034
[ { "id": "split_0_train_1034_passage", "type": "progene_text", "text": [ "We propose a model for the flagellar export apparatus in which FlhA and FlhB and the other four integral membrane proteins of the apparatus form a complex at the base of the flagellar motor ." ], "offsets": [ [ 0, 191 ] ] } ]
[ { "id": "split_0_train_1444_entity", "type": "progene_text", "text": [ "FlhA" ], "offsets": [ [ 63, 67 ] ], "normalized": [] }, { "id": "split_0_train_1445_entity", "type": "progene_text", "text": [ "FlhB" ], "offsets": [ [ 72, 76 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1035
split_0_train_1035
[ { "id": "split_0_train_1035_passage", "type": "progene_text", "text": [ "A soluble complex of at least three proteins ( FliH , FliI and FliJ ) bind the protein to be exported and then interact with the complex at the motor to deliver the protein , which is then exported in an ATP - dependent process mediated by FliI ." ], "offsets": [ [ 0, 246 ] ] } ]
[ { "id": "split_0_train_1446_entity", "type": "progene_text", "text": [ "FliH" ], "offsets": [ [ 47, 51 ] ], "normalized": [] }, { "id": "split_0_train_1447_entity", "type": "progene_text", "text": [ "FliI" ], "offsets": [ [ 54, 58 ] ], "normalized": [] }, { "id": "split_0_train_1448_entity", "type": "progene_text", "text": [ "FliJ" ], "offsets": [ [ 63, 67 ] ], "normalized": [] }, { "id": "split_0_train_1449_entity", "type": "progene_text", "text": [ "FliI" ], "offsets": [ [ 240, 244 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1036
split_0_train_1036
[ { "id": "split_0_train_1036_passage", "type": "progene_text", "text": [ "Distribution of neurons immunoreactive for calcium - binding proteins varies across areas of cat primary somatosensory cortex ." ], "offsets": [ [ 0, 127 ] ] } ]
[]
[]
[]
[]
split_0_train_1037
split_0_train_1037
[ { "id": "split_0_train_1037_passage", "type": "progene_text", "text": [ "The primary somatosensory ( SI ) cortex in the cat contains four cytoarchitectonic areas that appear to contain separate body representations and have different functions ." ], "offsets": [ [ 0, 172 ] ] } ]
[]
[]
[]
[]
split_0_train_1038
split_0_train_1038
[ { "id": "split_0_train_1038_passage", "type": "progene_text", "text": [ "We tested whether functional differences among these areas are reflected in the densities of neurons containing each of three calcium - binding proteins : parvalbumin ( PV ) , calbindin ( CB ) , and calretinin ( CR ) ." ], "offsets": [ [ 0, 218 ] ] } ]
[ { "id": "split_0_train_1450_entity", "type": "progene_text", "text": [ "parvalbumin" ], "offsets": [ [ 155, 166 ] ], "normalized": [] }, { "id": "split_0_train_1451_entity", "type": "progene_text", "text": [ "PV" ], "offsets": [ [ 169, 171 ] ], "normalized": [] }, { "id": "split_0_train_1452_entity", "type": "progene_text", "text": [ "calbindin" ], "offsets": [ [ 176, 185 ] ], "normalized": [] }, { "id": "split_0_train_1453_entity", "type": "progene_text", "text": [ "CB" ], "offsets": [ [ 188, 190 ] ], "normalized": [] }, { "id": "split_0_train_1454_entity", "type": "progene_text", "text": [ "calretinin" ], "offsets": [ [ 199, 209 ] ], "normalized": [] }, { "id": "split_0_train_1455_entity", "type": "progene_text", "text": [ "CR" ], "offsets": [ [ 212, 214 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1039
split_0_train_1039
[ { "id": "split_0_train_1039_passage", "type": "progene_text", "text": [ "Colocalization experiments revealed that CR was localized in a population of neurons distinct from those containing PV or CB ." ], "offsets": [ [ 0, 126 ] ] } ]
[ { "id": "split_0_train_1456_entity", "type": "progene_text", "text": [ "CR" ], "offsets": [ [ 41, 43 ] ], "normalized": [] }, { "id": "split_0_train_1457_entity", "type": "progene_text", "text": [ "PV" ], "offsets": [ [ 116, 118 ] ], "normalized": [] }, { "id": "split_0_train_1458_entity", "type": "progene_text", "text": [ "CB" ], "offsets": [ [ 122, 124 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1040
split_0_train_1040
[ { "id": "split_0_train_1040_passage", "type": "progene_text", "text": [ "The general laminar distributions of the three calcium - binding proteins were similar to those described in other species and cortical areas , but there were significant density differences in layers II and III across SI ." ], "offsets": [ [ 0, 223 ] ] } ]
[]
[]
[]
[]
split_0_train_1041
split_0_train_1041
[ { "id": "split_0_train_1041_passage", "type": "progene_text", "text": [ "The density of PV - immunoreactive neurons was higher in areas 3b and 1 than in areas 3a and 2 ." ], "offsets": [ [ 0, 96 ] ] } ]
[ { "id": "split_0_train_1459_entity", "type": "progene_text", "text": [ "PV" ], "offsets": [ [ 15, 17 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1042
split_0_train_1042
[ { "id": "split_0_train_1042_passage", "type": "progene_text", "text": [ "CB - immunoreactive neurons were found in higher densities in anterior SI than in posterior SI , and the pattern of CR - immunoreactive neurons was reciprocal to that of CB , with significantly higher densities in posterior regions of SI ." ], "offsets": [ [ 0, 239 ] ] } ]
[ { "id": "split_0_train_1460_entity", "type": "progene_text", "text": [ "CB" ], "offsets": [ [ 0, 2 ] ], "normalized": [] }, { "id": "split_0_train_1461_entity", "type": "progene_text", "text": [ "CR" ], "offsets": [ [ 116, 118 ] ], "normalized": [] }, { "id": "split_0_train_1462_entity", "type": "progene_text", "text": [ "CB" ], "offsets": [ [ 170, 172 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1043
split_0_train_1043
[ { "id": "split_0_train_1043_passage", "type": "progene_text", "text": [ "Since the firing characteristics of nonpyramidal neurons appear to be related to their calcium - binding protein content , differences in regional distributions of these neurons in layers II and III may contribute to functional differences between the cytoarchitectonic areas of SI cortex ." ], "offsets": [ [ 0, 290 ] ] } ]
[]
[]
[]
[]
split_0_train_1044
split_0_train_1044
[ { "id": "split_0_train_1044_passage", "type": "progene_text", "text": [ "Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells ." ], "offsets": [ [ 0, 94 ] ] } ]
[ { "id": "split_0_train_1463_entity", "type": "progene_text", "text": [ "plasminogen" ], "offsets": [ [ 14, 25 ] ], "normalized": [] }, { "id": "split_0_train_1464_entity", "type": "progene_text", "text": [ "TGF-beta" ], "offsets": [ [ 40, 48 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1045
split_0_train_1045
[ { "id": "split_0_train_1045_passage", "type": "progene_text", "text": [ "BACKGROUND / AIMS :" ], "offsets": [ [ 0, 19 ] ] } ]
[]
[]
[]
[]
split_0_train_1046
split_0_train_1046
[ { "id": "split_0_train_1046_passage", "type": "progene_text", "text": [ "Regulation of plasmin mediated extracellular matrix degradation by vascular endothelial cells is important in the development of angiogenesis ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_1465_entity", "type": "progene_text", "text": [ "plasmin" ], "offsets": [ [ 14, 21 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1047
split_0_train_1047
[ { "id": "split_0_train_1047_passage", "type": "progene_text", "text": [ "The aim was to determine whether transforming growth factor beta ( TGF-beta ) affected the regulation of components of the plasminogen system by human retinal endothelial cells , in order to define more clearly the role of TGF-beta in retinal angiogenesis in the context of diabetes mellitus ." ], "offsets": [ [ 0, 293 ] ] } ]
[ { "id": "split_0_train_1466_entity", "type": "progene_text", "text": [ "transforming growth factor beta" ], "offsets": [ [ 33, 64 ] ], "normalized": [] }, { "id": "split_0_train_1467_entity", "type": "progene_text", "text": [ "TGF-beta" ], "offsets": [ [ 67, 75 ] ], "normalized": [] }, { "id": "split_0_train_1468_entity", "type": "progene_text", "text": [ "plasminogen" ], "offsets": [ [ 123, 134 ] ], "normalized": [] }, { "id": "split_0_train_1469_entity", "type": "progene_text", "text": [ "TGF-beta" ], "offsets": [ [ 223, 231 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1048
split_0_train_1048
[ { "id": "split_0_train_1048_passage", "type": "progene_text", "text": [ "METHODS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_1049
split_0_train_1049
[ { "id": "split_0_train_1049_passage", "type": "progene_text", "text": [ "Human retinal endothelial cells ( HREC ) were isolated from donor eyes and used between passages 4-8 ." ], "offsets": [ [ 0, 102 ] ] } ]
[]
[]
[]
[]
split_0_train_1050
split_0_train_1050
[ { "id": "split_0_train_1050_passage", "type": "progene_text", "text": [ "The cells were cultured in medium supplemented with 2 , 5 , 15 , or 25 mM glucose , plus or minus TGF-beta ( 1 ng / ml ) ." ], "offsets": [ [ 0, 122 ] ] } ]
[ { "id": "split_0_train_1470_entity", "type": "progene_text", "text": [ "TGF-beta" ], "offsets": [ [ 98, 106 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1051
split_0_train_1051
[ { "id": "split_0_train_1051_passage", "type": "progene_text", "text": [ "The concentrations of tissue plasminogen activator (t-PA ) , urokinase plasminogen activator ( u-PA ) , and plasminogen activator inhibitor type 1 ( PAI-1 ) in cell conditioned medium were determined by ELISA and the level of PAI-1 mRNA was determined using northern hybridisation ." ], "offsets": [ [ 0, 282 ] ] } ]
[ { "id": "split_0_train_1471_entity", "type": "progene_text", "text": [ "tissue plasminogen activator" ], "offsets": [ [ 22, 50 ] ], "normalized": [] }, { "id": "split_0_train_1472_entity", "type": "progene_text", "text": [ "(t-PA" ], "offsets": [ [ 51, 56 ] ], "normalized": [] }, { "id": "split_0_train_1473_entity", "type": "progene_text", "text": [ "urokinase plasminogen activator" ], "offsets": [ [ 61, 92 ] ], "normalized": [] }, { "id": "split_0_train_1474_entity", "type": "progene_text", "text": [ "u-PA" ], "offsets": [ [ 95, 99 ] ], "normalized": [] }, { "id": "split_0_train_1475_entity", "type": "progene_text", "text": [ "plasminogen activator inhibitor type 1" ], "offsets": [ [ 108, 146 ] ], "normalized": [] }, { "id": "split_0_train_1476_entity", "type": "progene_text", "text": [ "PAI-1" ], "offsets": [ [ 149, 154 ] ], "normalized": [] }, { "id": "split_0_train_1477_entity", "type": "progene_text", "text": [ "PAI-1" ], "offsets": [ [ 226, 231 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1052
split_0_train_1052
[ { "id": "split_0_train_1052_passage", "type": "progene_text", "text": [ "Cell associated plasminogen activity was determined using a clot lysis assay and a chromogenic assay ." ], "offsets": [ [ 0, 102 ] ] } ]
[ { "id": "split_0_train_1478_entity", "type": "progene_text", "text": [ "plasminogen" ], "offsets": [ [ 16, 27 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1053
split_0_train_1053
[ { "id": "split_0_train_1053_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_1054
split_0_train_1054
[ { "id": "split_0_train_1054_passage", "type": "progene_text", "text": [ "Under basal conditions ( 5 mM glucose ) , HREC produced PAI-1 , t-PA , and trace amounts of u-PA ." ], "offsets": [ [ 0, 98 ] ] } ]
[ { "id": "split_0_train_1479_entity", "type": "progene_text", "text": [ "PAI-1" ], "offsets": [ [ 56, 61 ] ], "normalized": [] }, { "id": "split_0_train_1480_entity", "type": "progene_text", "text": [ "t-PA" ], "offsets": [ [ 64, 68 ] ], "normalized": [] }, { "id": "split_0_train_1481_entity", "type": "progene_text", "text": [ "u-PA" ], "offsets": [ [ 92, 96 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1055
split_0_train_1055
[ { "id": "split_0_train_1055_passage", "type": "progene_text", "text": [ "Cell surface plasminogen activation observed by lysis of fibrin or by cleavage of chromogenic substrate , was mediated by t-PA ." ], "offsets": [ [ 0, 128 ] ] } ]
[ { "id": "split_0_train_1482_entity", "type": "progene_text", "text": [ "fibrin" ], "offsets": [ [ 57, 63 ] ], "normalized": [] }, { "id": "split_0_train_1483_entity", "type": "progene_text", "text": [ "t-PA" ], "offsets": [ [ 122, 126 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1056
split_0_train_1056
[ { "id": "split_0_train_1056_passage", "type": "progene_text", "text": [ "Glucose at varying concentrations ( 2-25 mM ) had no significant effect on t-PA mediated clot lysis ." ], "offsets": [ [ 0, 101 ] ] } ]
[ { "id": "split_0_train_1484_entity", "type": "progene_text", "text": [ "t-PA" ], "offsets": [ [ 75, 79 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1057
split_0_train_1057
[ { "id": "split_0_train_1057_passage", "type": "progene_text", "text": [ "In contrast , treatment with TGF-beta resulted in increased synthesis of PAI-1 protein and mRNA ." ], "offsets": [ [ 0, 97 ] ] } ]
[ { "id": "split_0_train_1485_entity", "type": "progene_text", "text": [ "TGF-beta" ], "offsets": [ [ 29, 37 ] ], "normalized": [] }, { "id": "split_0_train_1486_entity", "type": "progene_text", "text": [ "PAI-1" ], "offsets": [ [ 73, 78 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1058
split_0_train_1058
[ { "id": "split_0_train_1058_passage", "type": "progene_text", "text": [ "The increased expression of the PAI-1 mRNAs by TGF-beta did not occur uniformly , the 2.3 kb mRNA transcript was preferentially increased in comparison with the 3.2 kb mRNA ( p < 0.05 ) ." ], "offsets": [ [ 0, 187 ] ] } ]
[ { "id": "split_0_train_1487_entity", "type": "progene_text", "text": [ "PAI-1" ], "offsets": [ [ 32, 37 ] ], "normalized": [] }, { "id": "split_0_train_1488_entity", "type": "progene_text", "text": [ "TGF-beta" ], "offsets": [ [ 47, 55 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1059
split_0_train_1059
[ { "id": "split_0_train_1059_passage", "type": "progene_text", "text": [ "CONCLUSIONS :" ], "offsets": [ [ 0, 13 ] ] } ]
[]
[]
[]
[]
split_0_train_1060
split_0_train_1060
[ { "id": "split_0_train_1060_passage", "type": "progene_text", "text": [ "These data demonstrate that TGF-beta increases PAI-1 and decreases cell associated lysis ." ], "offsets": [ [ 0, 90 ] ] } ]
[ { "id": "split_0_train_1489_entity", "type": "progene_text", "text": [ "TGF-beta" ], "offsets": [ [ 28, 36 ] ], "normalized": [] }, { "id": "split_0_train_1490_entity", "type": "progene_text", "text": [ "PAI-1" ], "offsets": [ [ 47, 52 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1061
split_0_train_1061
[ { "id": "split_0_train_1061_passage", "type": "progene_text", "text": [ "This is sufficient to decrease the normal lytic potential of HREC ." ], "offsets": [ [ 0, 67 ] ] } ]
[]
[]
[]
[]
split_0_train_1062
split_0_train_1062
[ { "id": "split_0_train_1062_passage", "type": "progene_text", "text": [ "Molecular cloning and characterization of mouse CD97 ." ], "offsets": [ [ 0, 54 ] ] } ]
[ { "id": "split_0_train_1491_entity", "type": "progene_text", "text": [ "CD97" ], "offsets": [ [ 48, 52 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1063
split_0_train_1063
[ { "id": "split_0_train_1063_passage", "type": "progene_text", "text": [ "The EGF-TM7 family ( CD97 and EMR1 ) is a group of class II seven - span transmembrane receptors predominantly expressed by cells of the immune system ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_1492_entity", "type": "progene_text", "text": [ "EGF-TM7 family" ], "offsets": [ [ 4, 18 ] ], "normalized": [] }, { "id": "split_0_train_1493_entity", "type": "progene_text", "text": [ "CD97" ], "offsets": [ [ 21, 25 ] ], "normalized": [] }, { "id": "split_0_train_1494_entity", "type": "progene_text", "text": [ "EMR1" ], "offsets": [ [ 30, 34 ] ], "normalized": [] }, { "id": "split_0_train_1495_entity", "type": "progene_text", "text": [ "seven - span transmembrane receptors" ], "offsets": [ [ 60, 96 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1064
split_0_train_1064
[ { "id": "split_0_train_1064_passage", "type": "progene_text", "text": [ "Recently , we have identified CD55 , a regulatory molecule of the complement cascade , as a cellular ligand of human CD97 ( hCD97 ) ." ], "offsets": [ [ 0, 133 ] ] } ]
[ { "id": "split_0_train_1496_entity", "type": "progene_text", "text": [ "CD55" ], "offsets": [ [ 30, 34 ] ], "normalized": [] }, { "id": "split_0_train_1497_entity", "type": "progene_text", "text": [ "CD97" ], "offsets": [ [ 117, 121 ] ], "normalized": [] }, { "id": "split_0_train_1498_entity", "type": "progene_text", "text": [ "hCD97" ], "offsets": [ [ 124, 129 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1065
split_0_train_1065
[ { "id": "split_0_train_1065_passage", "type": "progene_text", "text": [ "In this study , the molecular properties of mouse CD97 ( mCD97 ) are described ." ], "offsets": [ [ 0, 80 ] ] } ]
[ { "id": "split_0_train_1499_entity", "type": "progene_text", "text": [ "CD97" ], "offsets": [ [ 50, 54 ] ], "normalized": [] }, { "id": "split_0_train_1500_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 57, 62 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1066
split_0_train_1066
[ { "id": "split_0_train_1066_passage", "type": "progene_text", "text": [ "Like hCD97 , mCD97 has an extended extracellular region with several epidermal growth factor - like ( EGF ) domains ." ], "offsets": [ [ 0, 117 ] ] } ]
[ { "id": "split_0_train_1501_entity", "type": "progene_text", "text": [ "hCD97" ], "offsets": [ [ 5, 10 ] ], "normalized": [] }, { "id": "split_0_train_1502_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 13, 18 ] ], "normalized": [] }, { "id": "split_0_train_1503_entity", "type": "progene_text", "text": [ "epidermal growth factor" ], "offsets": [ [ 69, 92 ] ], "normalized": [] }, { "id": "split_0_train_1504_entity", "type": "progene_text", "text": [ "EGF" ], "offsets": [ [ 102, 105 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1067
split_0_train_1067
[ { "id": "split_0_train_1067_passage", "type": "progene_text", "text": [ "Due to alternative RNA splicing , isoforms with three and four EGF domains exist , designated mCD97 ( EGF1 , 2,4 ) and mCD97 ( EGF1 , 2 , 3,4 ) respectively ." ], "offsets": [ [ 0, 158 ] ] } ]
[ { "id": "split_0_train_1505_entity", "type": "progene_text", "text": [ "EGF" ], "offsets": [ [ 63, 66 ] ], "normalized": [] }, { "id": "split_0_train_1506_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 94, 99 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1068
split_0_train_1068
[ { "id": "split_0_train_1068_passage", "type": "progene_text", "text": [ "All EGF domains , except for the N - terminal one , possess a calcium - binding site ." ], "offsets": [ [ 0, 86 ] ] } ]
[ { "id": "split_0_train_1507_entity", "type": "progene_text", "text": [ "EGF" ], "offsets": [ [ 4, 7 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1069
split_0_train_1069
[ { "id": "split_0_train_1069_passage", "type": "progene_text", "text": [ "In a third isoform mCD97 ( EGF1,2,X,3,4 ) , a sequence of 45 amino acids was found between the second and third EGF domain that does not correspond to any known protein module ." ], "offsets": [ [ 0, 177 ] ] } ]
[ { "id": "split_0_train_1508_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 19, 24 ] ], "normalized": [] }, { "id": "split_0_train_1509_entity", "type": "progene_text", "text": [ "EGF" ], "offsets": [ [ 112, 115 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1070
split_0_train_1070
[ { "id": "split_0_train_1070_passage", "type": "progene_text", "text": [ "Using newly generated mCD97 mAb , we show that analogous to the blood expression pattern of hCD97 , mCD97 can be found on lymphoid and myeloid cells ." ], "offsets": [ [ 0, 150 ] ] } ]
[ { "id": "split_0_train_1510_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 22, 27 ] ], "normalized": [] }, { "id": "split_0_train_1511_entity", "type": "progene_text", "text": [ "hCD97" ], "offsets": [ [ 92, 97 ] ], "normalized": [] }, { "id": "split_0_train_1512_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 100, 105 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1071
split_0_train_1071
[ { "id": "split_0_train_1071_passage", "type": "progene_text", "text": [ "Adhesion of mouse erythrocytes and splenocytes to COS cells expressing mCD97 ( EGF1,2,4 ) or mCD97 ( EGF1 , 2 , 3 , 4 ) could be blocked by mouse CD55 ( mCD55 ) antibody , identifying mCD55 as a cellular ligand for mCD97 ." ], "offsets": [ [ 0, 222 ] ] } ]
[ { "id": "split_0_train_1513_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 71, 76 ] ], "normalized": [] }, { "id": "split_0_train_1514_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 93, 98 ] ], "normalized": [] }, { "id": "split_0_train_1515_entity", "type": "progene_text", "text": [ "CD55" ], "offsets": [ [ 146, 150 ] ], "normalized": [] }, { "id": "split_0_train_1516_entity", "type": "progene_text", "text": [ "mCD55" ], "offsets": [ [ 153, 158 ] ], "normalized": [] }, { "id": "split_0_train_1517_entity", "type": "progene_text", "text": [ "mCD55" ], "offsets": [ [ 184, 189 ] ], "normalized": [] }, { "id": "split_0_train_1518_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 215, 220 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1072
split_0_train_1072
[ { "id": "split_0_train_1072_passage", "type": "progene_text", "text": [ "Consistent with the necessity of directly linked EGF domains for the integrity of the CD55 - binding site on hCD97 , no adhesion was detected to the largest mouse isoform mCD97 ( EGF1 , 2 , X,3,4 ) ." ], "offsets": [ [ 0, 199 ] ] } ]
[ { "id": "split_0_train_1519_entity", "type": "progene_text", "text": [ "EGF" ], "offsets": [ [ 49, 52 ] ], "normalized": [] }, { "id": "split_0_train_1520_entity", "type": "progene_text", "text": [ "CD55" ], "offsets": [ [ 86, 90 ] ], "normalized": [] }, { "id": "split_0_train_1521_entity", "type": "progene_text", "text": [ "hCD97" ], "offsets": [ [ 109, 114 ] ], "normalized": [] }, { "id": "split_0_train_1522_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 171, 176 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1073
split_0_train_1073
[ { "id": "split_0_train_1073_passage", "type": "progene_text", "text": [ "Remarkably , we found that the interaction between CD97 and CD55 is phylogenetically restricted , as indicated by the selective adhesion of primate erythrocytes to hCD97 transfectants , and of mouse and rat erythrocytes to mCD97 transfectants respectively ." ], "offsets": [ [ 0, 257 ] ] } ]
[ { "id": "split_0_train_1523_entity", "type": "progene_text", "text": [ "CD97" ], "offsets": [ [ 51, 55 ] ], "normalized": [] }, { "id": "split_0_train_1524_entity", "type": "progene_text", "text": [ "CD55" ], "offsets": [ [ 60, 64 ] ], "normalized": [] }, { "id": "split_0_train_1525_entity", "type": "progene_text", "text": [ "hCD97" ], "offsets": [ [ 164, 169 ] ], "normalized": [] }, { "id": "split_0_train_1526_entity", "type": "progene_text", "text": [ "mCD97" ], "offsets": [ [ 223, 228 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1074
split_0_train_1074
[ { "id": "split_0_train_1074_passage", "type": "progene_text", "text": [ "Regulation of expression of the human beta-1,2-N-acetylglucosaminyltransferase II gene ( MGAT2 ) by Ets transcription factors ." ], "offsets": [ [ 0, 127 ] ] } ]
[ { "id": "split_0_train_1527_entity", "type": "progene_text", "text": [ "beta-1,2-N-acetylglucosaminyltransferase II" ], "offsets": [ [ 38, 81 ] ], "normalized": [] }, { "id": "split_0_train_1528_entity", "type": "progene_text", "text": [ "MGAT2" ], "offsets": [ [ 89, 94 ] ], "normalized": [] }, { "id": "split_0_train_1529_entity", "type": "progene_text", "text": [ "Ets" ], "offsets": [ [ 100, 103 ] ], "normalized": [] }, { "id": "split_0_train_1530_entity", "type": "progene_text", "text": [ "transcription factors" ], "offsets": [ [ 104, 125 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1075
split_0_train_1075
[ { "id": "split_0_train_1075_passage", "type": "progene_text", "text": [ "Oncogenic transformation of fibroblasts by the src oncogene has long been known to cause an increase in the size of cell - surface protein - bound oligosaccharides , owing primarily to increased N - glycan branching mediated by increased beta-1,6-N-acetylglucosaminyltransferase V ( GnT V ) activity ." ], "offsets": [ [ 0, 301 ] ] } ]
[ { "id": "split_0_train_1531_entity", "type": "progene_text", "text": [ "src" ], "offsets": [ [ 47, 50 ] ], "normalized": [] }, { "id": "split_0_train_1532_entity", "type": "progene_text", "text": [ "beta-1,6-N-acetylglucosaminyltransferase V" ], "offsets": [ [ 238, 280 ] ], "normalized": [] }, { "id": "split_0_train_1533_entity", "type": "progene_text", "text": [ "GnT V" ], "offsets": [ [ 283, 288 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1076
split_0_train_1076
[ { "id": "split_0_train_1076_passage", "type": "progene_text", "text": [ "The src - responsive element of the GnT V promoter was localized to Ets - binding sites and the promoter was transcriptionally stimulated by both ets-1 and ets-2 expression [ Buckhaults , Chen , Fregien and Pierce ( 1997 ) J. Biol. Chem. 272 , 19575 - 19581 ; Kang , Saito , Ihara , Miyoshi , Koyama , Sheng and Taniguchi ( 1996 ) J. Biol. Chem. 271 , 26706 - 26712 ] ." ], "offsets": [ [ 0, 369 ] ] } ]
[ { "id": "split_0_train_1534_entity", "type": "progene_text", "text": [ "src" ], "offsets": [ [ 4, 7 ] ], "normalized": [] }, { "id": "split_0_train_1535_entity", "type": "progene_text", "text": [ "GnT V" ], "offsets": [ [ 36, 41 ] ], "normalized": [] }, { "id": "split_0_train_1536_entity", "type": "progene_text", "text": [ "Ets" ], "offsets": [ [ 68, 71 ] ], "normalized": [] }, { "id": "split_0_train_1537_entity", "type": "progene_text", "text": [ "ets-1" ], "offsets": [ [ 146, 151 ] ], "normalized": [] }, { "id": "split_0_train_1538_entity", "type": "progene_text", "text": [ "ets-2" ], "offsets": [ [ 156, 161 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1077
split_0_train_1077
[ { "id": "split_0_train_1077_passage", "type": "progene_text", "text": [ "Because GnT V action requires the prior action of beta-1,2-N-acetylglucosaminyltransferase II ( GnT II ) and the human GnT II promoter contains four putative Ets - binding sites [ Chen , Zhou , Tan and Schachter ( 1998 ) Glycoconj. J. 15 , 301 - 308 ] , GnT II might also be under oncogenic control via Ets transcription factors ." ], "offsets": [ [ 0, 330 ] ] } ]
[ { "id": "split_0_train_1539_entity", "type": "progene_text", "text": [ "GnT V" ], "offsets": [ [ 8, 13 ] ], "normalized": [] }, { "id": "split_0_train_1540_entity", "type": "progene_text", "text": [ "beta-1,2-N-acetylglucosaminyltransferase II" ], "offsets": [ [ 50, 93 ] ], "normalized": [] }, { "id": "split_0_train_1541_entity", "type": "progene_text", "text": [ "GnT II" ], "offsets": [ [ 96, 102 ] ], "normalized": [] }, { "id": "split_0_train_1542_entity", "type": "progene_text", "text": [ "GnT II" ], "offsets": [ [ 119, 125 ] ], "normalized": [] }, { "id": "split_0_train_1543_entity", "type": "progene_text", "text": [ "Ets" ], "offsets": [ [ 158, 161 ] ], "normalized": [] }, { "id": "split_0_train_1544_entity", "type": "progene_text", "text": [ "GnT II" ], "offsets": [ [ 254, 260 ] ], "normalized": [] }, { "id": "split_0_train_1545_entity", "type": "progene_text", "text": [ "Ets" ], "offsets": [ [ 303, 306 ] ], "normalized": [] }, { "id": "split_0_train_1546_entity", "type": "progene_text", "text": [ "transcription factors" ], "offsets": [ [ 307, 328 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1078
split_0_train_1078
[ { "id": "split_0_train_1078_passage", "type": "progene_text", "text": [ "We now report that co - transfection into HepG2 or COS-1 cells of either ets-1 or ets-2 expression plasmids together with chimaeric GnT II promoter - chloramphenicol acetyltransferase plasmids results in a 2 - 4 - fold stimulation of promoter activity ." ], "offsets": [ [ 0, 253 ] ] } ]
[ { "id": "split_0_train_1547_entity", "type": "progene_text", "text": [ "ets-1" ], "offsets": [ [ 73, 78 ] ], "normalized": [] }, { "id": "split_0_train_1548_entity", "type": "progene_text", "text": [ "ets-2" ], "offsets": [ [ 82, 87 ] ], "normalized": [] }, { "id": "split_0_train_1549_entity", "type": "progene_text", "text": [ "GnT II" ], "offsets": [ [ 132, 138 ] ], "normalized": [] }, { "id": "split_0_train_1550_entity", "type": "progene_text", "text": [ "chloramphenicol acetyltransferase" ], "offsets": [ [ 150, 183 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1079
split_0_train_1079
[ { "id": "split_0_train_1079_passage", "type": "progene_text", "text": [ "Mobility - shift assays and South - Western blots localized the functional Ets - binding site to one of the four putative sites on the GnT II promoter ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_1551_entity", "type": "progene_text", "text": [ "Ets" ], "offsets": [ [ 75, 78 ] ], "normalized": [] }, { "id": "split_0_train_1552_entity", "type": "progene_text", "text": [ "GnT II" ], "offsets": [ [ 135, 141 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1080
split_0_train_1080
[ { "id": "split_0_train_1080_passage", "type": "progene_text", "text": [ "The GnT II promoter , unlike the GnT V promoter , is not activated by either src or neu ." ], "offsets": [ [ 0, 89 ] ] } ]
[ { "id": "split_0_train_1553_entity", "type": "progene_text", "text": [ "GnT II" ], "offsets": [ [ 4, 10 ] ], "normalized": [] }, { "id": "split_0_train_1554_entity", "type": "progene_text", "text": [ "GnT V" ], "offsets": [ [ 33, 38 ] ], "normalized": [] }, { "id": "split_0_train_1555_entity", "type": "progene_text", "text": [ "src" ], "offsets": [ [ 77, 80 ] ], "normalized": [] }, { "id": "split_0_train_1556_entity", "type": "progene_text", "text": [ "neu" ], "offsets": [ [ 84, 87 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1081
split_0_train_1081
[ { "id": "split_0_train_1081_passage", "type": "progene_text", "text": [ "Therefore although both promoters are stimulated by a member of the Ets family of transcription factors , the functional role of this Ets transcriptional control seems to be different for the two genes ." ], "offsets": [ [ 0, 203 ] ] } ]
[ { "id": "split_0_train_1557_entity", "type": "progene_text", "text": [ "Ets family" ], "offsets": [ [ 68, 78 ] ], "normalized": [] }, { "id": "split_0_train_1558_entity", "type": "progene_text", "text": [ "transcription factors" ], "offsets": [ [ 82, 103 ] ], "normalized": [] }, { "id": "split_0_train_1559_entity", "type": "progene_text", "text": [ "Ets" ], "offsets": [ [ 134, 137 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1082
split_0_train_1082
[ { "id": "split_0_train_1082_passage", "type": "progene_text", "text": [ "Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas ." ], "offsets": [ [ 0, 89 ] ] } ]
[ { "id": "split_0_train_1560_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 15, 26 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1083
split_0_train_1083
[ { "id": "split_0_train_1083_passage", "type": "progene_text", "text": [ "Our analyses of cathepsin H activity levels and protein forms in human colorectal cancers compared to matched control mucosa support the concept that altered proteinase expression patterns may reflect both cancer stage and site ." ], "offsets": [ [ 0, 229 ] ] } ]
[ { "id": "split_0_train_1561_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 16, 27 ] ], "normalized": [] }, { "id": "split_0_train_1562_entity", "type": "progene_text", "text": [ "proteinase" ], "offsets": [ [ 158, 168 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1084
split_0_train_1084
[ { "id": "split_0_train_1084_passage", "type": "progene_text", "text": [ "Cathepsin H - specific activity was significantly increased in colorectal cancers compared to control mucosa ( P = 0.003 ; n = 77 ) ." ], "offsets": [ [ 0, 133 ] ] } ]
[ { "id": "split_0_train_1563_entity", "type": "progene_text", "text": [ "Cathepsin H" ], "offsets": [ [ 0, 11 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1085
split_0_train_1085
[ { "id": "split_0_train_1085_passage", "type": "progene_text", "text": [ "Highest specific activities and cancer / normal ratios ( C / N ) for activity were measured in Dukes ' B and C stage carcinomas , cancers involved in local spread and invasion to lymph nodes ." ], "offsets": [ [ 0, 192 ] ] } ]
[]
[]
[]
[]
split_0_train_1086
split_0_train_1086
[ { "id": "split_0_train_1086_passage", "type": "progene_text", "text": [ "In contrast , cathepsin B and L activities analysed in the same paired extracts had been shown to be most frequently elevated in earlier stage carcinomas ( Dukes ' A and B ) , confirming that cathepsin H demonstrates a distinct pattern of expression during colorectal cancer progression ." ], "offsets": [ [ 0, 288 ] ] } ]
[ { "id": "split_0_train_1564_entity", "type": "progene_text", "text": [ "cathepsin B and L" ], "offsets": [ [ 14, 31 ] ], "normalized": [] }, { "id": "split_0_train_1565_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 192, 203 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1087
split_0_train_1087
[ { "id": "split_0_train_1087_passage", "type": "progene_text", "text": [ "Although cathepsin H activities were most commonly elevated in Dukes ' C cancers at all colon sites , both specific activity and C / N ratios were significantly higher for cancers of the left colon compared to other colon locations ." ], "offsets": [ [ 0, 233 ] ] } ]
[ { "id": "split_0_train_1566_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 9, 20 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1088
split_0_train_1088
[ { "id": "split_0_train_1088_passage", "type": "progene_text", "text": [ "A subset of 43 paired extracts analysed on Western blots also revealed consistent changes in cathepsin H protein forms in cancers ." ], "offsets": [ [ 0, 131 ] ] } ]
[ { "id": "split_0_train_1567_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 93, 104 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1089
split_0_train_1089
[ { "id": "split_0_train_1089_passage", "type": "progene_text", "text": [ "Normal mucosa typically showed a strong protein doublet at 31 and 29 kDa while cancers demonstrated decreased expression or total loss of the 31 kDa protein ( 90 % of cases ) , equal or increased expression of the 29 - kDa protein ( 67 % of cases ) and the new appearance or up - regulation of a cathepsin H band at 22 kDa ( 78 % of cases ) ." ], "offsets": [ [ 0, 342 ] ] } ]
[ { "id": "split_0_train_1568_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 296, 307 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1090
split_0_train_1090
[ { "id": "split_0_train_1090_passage", "type": "progene_text", "text": [ "C / N ratios for cathepsin H enzyme activity correlated significantly with C / N ratios for the 29 kDa mature single - chain protein form ( P < 0.001 ) , with increased activity most commonly associated with elevated expression of 29 - kDa cathepsin H but also with up - regulation of the 22 - kDa band , suggesting a shift to more fully processed , mature active cathepsin H protein forms in cancers ." ], "offsets": [ [ 0, 402 ] ] } ]
[ { "id": "split_0_train_1569_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 17, 28 ] ], "normalized": [] }, { "id": "split_0_train_1570_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 240, 251 ] ], "normalized": [] }, { "id": "split_0_train_1571_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 364, 375 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1091
split_0_train_1091
[ { "id": "split_0_train_1091_passage", "type": "progene_text", "text": [ "Changes in cathepsin H expression were also detected by immunohistochemistry as elevated cathepsin H staining in tumour epithelial cells ." ], "offsets": [ [ 0, 138 ] ] } ]
[ { "id": "split_0_train_1572_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 11, 22 ] ], "normalized": [] }, { "id": "split_0_train_1573_entity", "type": "progene_text", "text": [ "cathepsin H" ], "offsets": [ [ 89, 100 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1092
split_0_train_1092
[ { "id": "split_0_train_1092_passage", "type": "progene_text", "text": [ "Tunicamycin enhances the anticellular activity of interferon by inhibiting G1 / S phase progression in 3T3 cells ." ], "offsets": [ [ 0, 114 ] ] } ]
[ { "id": "split_0_train_1574_entity", "type": "progene_text", "text": [ "interferon" ], "offsets": [ [ 50, 60 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1093
split_0_train_1093
[ { "id": "split_0_train_1093_passage", "type": "progene_text", "text": [ "We have shown earlier that the cell growth inhibitory activity of interferon ( IFN ) is significantly enhanced by tunicamycin ( TM ) ( Maheshwari et al. , Science 219 , 1339 - 1341 , 1983 ) ." ], "offsets": [ [ 0, 191 ] ] } ]
[ { "id": "split_0_train_1575_entity", "type": "progene_text", "text": [ "interferon" ], "offsets": [ [ 66, 76 ] ], "normalized": [] }, { "id": "split_0_train_1576_entity", "type": "progene_text", "text": [ "IFN" ], "offsets": [ [ 79, 82 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1094
split_0_train_1094
[ { "id": "split_0_train_1094_passage", "type": "progene_text", "text": [ "In this report , we investigated various regulatory points of synergistic action between TM and IFN-alpha / beta that inhibit cell growth in NIH 3T3 cells ." ], "offsets": [ [ 0, 156 ] ] } ]
[ { "id": "split_0_train_1577_entity", "type": "progene_text", "text": [ "IFN-alpha / beta" ], "offsets": [ [ 96, 112 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1095
split_0_train_1095
[ { "id": "split_0_train_1095_passage", "type": "progene_text", "text": [ "The MTT ( 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide ) viability assays showed a dose - dependent increase in percentage inhibition of the cells when treated with either TM or IFN ." ], "offsets": [ [ 0, 200 ] ] } ]
[ { "id": "split_0_train_1578_entity", "type": "progene_text", "text": [ "IFN" ], "offsets": [ [ 195, 198 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1096
split_0_train_1096
[ { "id": "split_0_train_1096_passage", "type": "progene_text", "text": [ "When doses of TM and IFN that had no significant inhibition on cell viability were used in combination , there was a pronounced suppression of DNA synthesis ( tritiated thymidine incorporation ) ." ], "offsets": [ [ 0, 196 ] ] } ]
[ { "id": "split_0_train_1579_entity", "type": "progene_text", "text": [ "IFN" ], "offsets": [ [ 21, 24 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1097
split_0_train_1097
[ { "id": "split_0_train_1097_passage", "type": "progene_text", "text": [ "Flow cytometry studies revealed that individual treatments with either IFN or TM that did not alter the cell cycle profile , when combined , resulted in an impaired cell cycle by inhibiting G1 / S progression ." ], "offsets": [ [ 0, 210 ] ] } ]
[ { "id": "split_0_train_1580_entity", "type": "progene_text", "text": [ "IFN" ], "offsets": [ [ 71, 74 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1098
split_0_train_1098
[ { "id": "split_0_train_1098_passage", "type": "progene_text", "text": [ "The blockage of G1 / S transition was associated with reduction of cyclin - dependent kinase ( CDK4 ) activity ." ], "offsets": [ [ 0, 112 ] ] } ]
[ { "id": "split_0_train_1581_entity", "type": "progene_text", "text": [ "cyclin - dependent kinase" ], "offsets": [ [ 67, 92 ] ], "normalized": [] }, { "id": "split_0_train_1582_entity", "type": "progene_text", "text": [ "CDK4" ], "offsets": [ [ 95, 99 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_1099
split_0_train_1099
[ { "id": "split_0_train_1099_passage", "type": "progene_text", "text": [ "The mRNA ( analyzed by ribonuclease protection assay ) and protein levels ( assayed by Western blotting ) of cyclins D1 , D3 , and CDK4 were downregulated by combined treatment with IFN and TM ." ], "offsets": [ [ 0, 194 ] ] } ]
[ { "id": "split_0_train_1583_entity", "type": "progene_text", "text": [ "ribonuclease" ], "offsets": [ [ 23, 35 ] ], "normalized": [] }, { "id": "split_0_train_1584_entity", "type": "progene_text", "text": [ "cyclins D1 , D3" ], "offsets": [ [ 109, 124 ] ], "normalized": [] }, { "id": "split_0_train_1585_entity", "type": "progene_text", "text": [ "CDK4" ], "offsets": [ [ 131, 135 ] ], "normalized": [] }, { "id": "split_0_train_1586_entity", "type": "progene_text", "text": [ "IFN" ], "offsets": [ [ 182, 185 ] ], "normalized": [] } ]
[]
[]
[]